Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

NCT00701870 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Study TLK199.2102 was terminated for lack of enrollment.

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: ezatiostat hydrochloride (Telintra®)

Sponsor

Telik